{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:10:38Z","timestamp":1772766638110,"version":"3.50.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/mph.0b013e3182441588","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T21:30:11Z","timestamp":1371159011000},"page":"e295-e297","source":"Crossref","is-referenced-by-count":10,"title":["Docetaxel in the Treatment of Children With Refractory or Relapsed Hepatoblastoma"],"prefix":"10.1097","volume":"34","author":[{"given":"Sally L.","family":"George","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Broster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia C.","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penelope","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-32-20210227","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.","volume":"361","author":"Perilongo","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-32-20210227","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","article-title":"Risk adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric OncologySIOPEL 2.","volume":"40","author":"Perilongo","year":"2004","journal-title":"Eur J Cancer"},{"key":"R3-32-20210227","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2000.18.14.2665","article-title":"Randomized comparison of cisplatinvincristinefluorouracil and cisplatincontinuous infusion doxorubicin for treatment of paediatric hepatoblastoma: a report from the childrens cancer group and the Pediatric Oncology Group.","volume":"18","author":"Ortega","year":"2000","journal-title":"J Clin Oncol"},{"key":"R4-32-20210227","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2008-1043805","article-title":"Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 99 and Hb 94.","volume":"211","author":"Fuchs","year":"1999","journal-title":"Klin Padiatr"},{"key":"R5-32-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.2009.22.4857","article-title":"Successful treatment of childhood high-risk hepatoblastoma with dose intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.","volume":"28","author":"Zsiros","year":"2010","journal-title":"J Clin Oncol"},{"key":"R6-32-20210227","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/cncr.21779","article-title":"Phase II investigation of docetaxel in pediatric patients with recurrent solid tumours. A report from the childrens oncology group.","volume":"106","author":"Zwerding","year":"2006","journal-title":"Cancer"},{"key":"R7-32-20210227","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00043426-199705000-00002","article-title":"Pediatric phase II cancer trials: a Pediatric Oncology Group study.","volume":"19","author":"Weitman","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"R8-32-20210227","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.ejca.2004.01.042","article-title":"Phase II study of high dose cyclophosphamide in relapsing andor resistant hepatoblastoma in children: a study from the SIOPEL group.","volume":"40","author":"Cacciavillano","year":"2004","journal-title":"Eur J Cancer"},{"key":"R9-32-20210227","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<209::AID-MPO8>3.0.CO;2-0","article-title":"Paclitaxel: an effective antineoplastic agent in the treatment of xenotransplanted hepatoblastoma.","volume":"32","author":"Fuchs","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"R10-32-20210227","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00247-006-0361-5","article-title":"2005 PRETEXT: a revised strategy system for primary malignant liver tumours of childhood developed by the SIOPEL group.","volume":"37","author":"Roebuck","year":"2007","journal-title":"Pediatr Radiol"},{"key":"R12-32-20210227","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1200\/JCO.1997.15.4.1538","article-title":"Phase 1 trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumours. A collaborative pediatric branch, national cancer institute and childrens cancer group trial.","volume":"15","author":"Blaney","year":"1997","journal-title":"J Clin Oncol"},{"key":"R13-32-20210227","first-page":"733","article-title":"Phase 1 trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Childrens Cancer Group trial.","volume":"5","author":"Seibel","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R14-32-20210227","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/cncr.23586","article-title":"Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma.","volume":"113","author":"Navid","year":"2008","journal-title":"Cancer"},{"key":"R15-32-20210227","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ijrobp.2008.05.028","article-title":"Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation cisplatin and docetaxel chemotherapy.","volume":"73","author":"Varan","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e3182441588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:12:04Z","timestamp":1620965524000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201210000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3182441588","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}